Control of Asthma Patients Symptomatic on Inhaled Corticosteroids

NCT00330070 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: IPL512,602 20 mg once daily
DRUG: IPL512,602 Matching Placebo once daily

Sponsor

Inflazyme Pharmaceuticals Ltd